Entheon Biomedical Corp.
Canadian Securities ExchangeTotal Valuation
Entheon Biomedical Corp. carries a market capitalization of 1.39M, placing it among publicly traded companies globally.
| Market Cap | 1.39M |
| Enterprise Value | N/A |
Share Statistics
Entheon Biomedical Corp. currently has 13.86M shares outstanding.
| Shares Outstanding | 13.86M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -4.38 |
| P/TBV Ratio | 2.92 |
| P/FCF Ratio | -3.27 |
| P/OCF Ratio | -3.27 |
Financial Position
Entheon Biomedical Corp. maintains a current ratio of 27.75, meaning it holds 27.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 27.75 |
| Quick Ratio | 26.09 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -96.92 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Entheon Biomedical Corp.'s stock has declined approximately -62.96296% over the past 52 weeks. The 50-day moving average sits at 0.09, while the 200-day moving average is 0.10.
| Beta (5Y) | N/A |
| 52-Week Price Change | -62.96296% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.10 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -370,669.00, while operating income came in at -370,669.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -370,669.00 |
| Pretax Income | -360,607.00 |
| Net Income | -360,607.00 |
| EBITDA | -370,669.00 |
| EBIT | -370,669.00 |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Total book value stands at -290,942.00, with working capital of 431,145.00 providing operational flexibility.
| Cash & Cash Equivalents | 409,384.00 |
| Total Debt | N/A |
| Net Debt | -409,384.00 |
| Equity (Book Value) | -290,942.00 |
| Book Value Per Share | -0.03 |
| Working Capital | 431,145.00 |
Cash Flow
Entheon Biomedical Corp. produced -389,753.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -389,753.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -389,753.00 |
| FCF Per Share | -0.03 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -39.25 |
| FCF Yield | -30.59 |
Stock Splits
Entheon Biomedical Corp.'s most recent stock split took place on March 1, 2024 with a 10:1 split ratio.
| Last Split Date | 3/1/2024 |
| Split Ratio | 10:1 |
Scores
Entheon Biomedical Corp. posts an Altman Z-Score of -18.83, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -18.83 |